PD
WST icon

Point72 (DIFC)’s West Pharmaceutical WST Stock Holding History

Point72 (DIFC)’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$110K Buy
+420
New +$102K 0.01% 559

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Point72 (DIFC)'s WST Position: Q3 2025 in Review

Point72 (DIFC) opened a new position in West Pharmaceutical (WST) in Q3 2025: 420 shares worth $110K. The stake represents 0.01% of the portfolio and ranks #559 among its holdings.

756 funds tracked by Wall St. Rank hold WST as of Q3 2025.

  • Point72 (DIFC) held 420 shares of West Pharmaceutical worth $110K as of Q3 2025.
  • West Pharmaceutical was a new Point72 (DIFC) position in Q3 2025.
  • West Pharmaceutical made up 0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #559 holding.
  • 756 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.